Legend Biotech Corp (LEGN) Total Liabilities (2019 - 2024)
Legend Biotech (LEGN) has disclosed Total Liabilities for 6 consecutive years, with $629.6 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Total Liabilities rose 5.42% year-over-year to $629.6 million, compared with a TTM value of $629.6 million through Dec 2024, up 5.42%, and an annual FY2024 reading of $629.6 million, up 5.42% over the prior year.
- Total Liabilities was $629.6 million for Q4 2024 at Legend Biotech, up from $597.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $629.6 million in Q4 2024 and bottomed at -$744.3 million in Q4 2022.
- Average Total Liabilities over 5 years is $192.1 million, with a median of $353.5 million recorded in 2021.
- The sharpest move saw Total Liabilities soared 184.36% in 2021, then plummeted 310.54% in 2022.
- Year by year, Total Liabilities stood at $124.3 million in 2020, then surged by 184.36% to $353.5 million in 2021, then tumbled by 310.54% to -$744.3 million in 2022, then skyrocketed by 180.24% to $597.2 million in 2023, then increased by 5.42% to $629.6 million in 2024.
- Business Quant data shows Total Liabilities for LEGN at $629.6 million in Q4 2024, $597.2 million in Q4 2023, and -$744.3 million in Q4 2022.